Cargando…

Global cancer research in the era of COVID-19: a bibliometric analysis

BACKGROUND: Patients with cancer across the world have been impacted by the COVID-19 pandemic due to increased risk of infection and disruption to cancer diagnosis and treatment. Widening of healthcare disparities is expected as the gap between health systems with and without adequate resources to m...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Hemelrijck, Mieke, Lewison, Grant, Fox, Louis, Vanderpuye, Verna DNK, Murillo, Raúl, Booth, Chris M, Canfell, Karen, Pramesh, C S, Sullivan, Richard, Mukherij, Deborah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426029/
https://www.ncbi.nlm.nih.gov/pubmed/34567249
http://dx.doi.org/10.3332/ecancer.2021.1264
_version_ 1783749961048915968
author Van Hemelrijck, Mieke
Lewison, Grant
Fox, Louis
Vanderpuye, Verna DNK
Murillo, Raúl
Booth, Chris M
Canfell, Karen
Pramesh, C S
Sullivan, Richard
Mukherij, Deborah
author_facet Van Hemelrijck, Mieke
Lewison, Grant
Fox, Louis
Vanderpuye, Verna DNK
Murillo, Raúl
Booth, Chris M
Canfell, Karen
Pramesh, C S
Sullivan, Richard
Mukherij, Deborah
author_sort Van Hemelrijck, Mieke
collection PubMed
description BACKGROUND: Patients with cancer across the world have been impacted by the COVID-19 pandemic due to increased risk of infection and disruption to cancer diagnosis and treatment. Widening of healthcare disparities is expected as the gap between health systems with and without adequate resources to mitigate the pandemic become more apparent. We undertook a bibliometric analysis of research related to cancer and COVID-19 to understand (1) the type of research that has been conducted (e.g. patients, services and systems) and (2) whether the pandemic has impacted the state of global cancer research as measured by research outputs to date. METHODS: An existing filter for cancer research consisting of title words and the names of specialist cancer journals was used to identify cancer and COVID-19 related articles and reviews in the Web of Science (©Clarivate Analytics) between January 2019 and February 2021. RESULTS: One thousand five hundred and forty-five publications were identified. The majority (57%) were reviews, opinion pieces or concerned with modelling impact of delays to diagnosis and treatment. The main research domains focused on managing or estimating COVID-19 risk to cancer patients accounting for 384 papers (25%). High Income countries contributed the largest volume (n = 1,115; 72%), compared to Upper Middle (n = 302; 20%), Lower Middle (n = 122; 8%) and Low Income countries (n = 2.4; 0.2%). No evidence of a reduction in global cancer research output was observed in 2020. CONCLUSIONS: We observed a shift in research focus rather than a decline in absolute output. However, there is variation based on national income and collaborations are minimal. There has been a focus on pan-cancer studies rather than cancer site-specific studies. Strengthening global multidisciplinary research partnerships with teams from diverse backgrounds with regard to gender, clinical expertise and resource setting is essential to prevent the widening of cancer inequalities.
format Online
Article
Text
id pubmed-8426029
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cancer Intelligence
record_format MEDLINE/PubMed
spelling pubmed-84260292021-09-24 Global cancer research in the era of COVID-19: a bibliometric analysis Van Hemelrijck, Mieke Lewison, Grant Fox, Louis Vanderpuye, Verna DNK Murillo, Raúl Booth, Chris M Canfell, Karen Pramesh, C S Sullivan, Richard Mukherij, Deborah Ecancermedicalscience Research BACKGROUND: Patients with cancer across the world have been impacted by the COVID-19 pandemic due to increased risk of infection and disruption to cancer diagnosis and treatment. Widening of healthcare disparities is expected as the gap between health systems with and without adequate resources to mitigate the pandemic become more apparent. We undertook a bibliometric analysis of research related to cancer and COVID-19 to understand (1) the type of research that has been conducted (e.g. patients, services and systems) and (2) whether the pandemic has impacted the state of global cancer research as measured by research outputs to date. METHODS: An existing filter for cancer research consisting of title words and the names of specialist cancer journals was used to identify cancer and COVID-19 related articles and reviews in the Web of Science (©Clarivate Analytics) between January 2019 and February 2021. RESULTS: One thousand five hundred and forty-five publications were identified. The majority (57%) were reviews, opinion pieces or concerned with modelling impact of delays to diagnosis and treatment. The main research domains focused on managing or estimating COVID-19 risk to cancer patients accounting for 384 papers (25%). High Income countries contributed the largest volume (n = 1,115; 72%), compared to Upper Middle (n = 302; 20%), Lower Middle (n = 122; 8%) and Low Income countries (n = 2.4; 0.2%). No evidence of a reduction in global cancer research output was observed in 2020. CONCLUSIONS: We observed a shift in research focus rather than a decline in absolute output. However, there is variation based on national income and collaborations are minimal. There has been a focus on pan-cancer studies rather than cancer site-specific studies. Strengthening global multidisciplinary research partnerships with teams from diverse backgrounds with regard to gender, clinical expertise and resource setting is essential to prevent the widening of cancer inequalities. Cancer Intelligence 2021-07-07 /pmc/articles/PMC8426029/ /pubmed/34567249 http://dx.doi.org/10.3332/ecancer.2021.1264 Text en © the authors; licensee ecancermedicalscience. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Van Hemelrijck, Mieke
Lewison, Grant
Fox, Louis
Vanderpuye, Verna DNK
Murillo, Raúl
Booth, Chris M
Canfell, Karen
Pramesh, C S
Sullivan, Richard
Mukherij, Deborah
Global cancer research in the era of COVID-19: a bibliometric analysis
title Global cancer research in the era of COVID-19: a bibliometric analysis
title_full Global cancer research in the era of COVID-19: a bibliometric analysis
title_fullStr Global cancer research in the era of COVID-19: a bibliometric analysis
title_full_unstemmed Global cancer research in the era of COVID-19: a bibliometric analysis
title_short Global cancer research in the era of COVID-19: a bibliometric analysis
title_sort global cancer research in the era of covid-19: a bibliometric analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426029/
https://www.ncbi.nlm.nih.gov/pubmed/34567249
http://dx.doi.org/10.3332/ecancer.2021.1264
work_keys_str_mv AT vanhemelrijckmieke globalcancerresearchintheeraofcovid19abibliometricanalysis
AT lewisongrant globalcancerresearchintheeraofcovid19abibliometricanalysis
AT foxlouis globalcancerresearchintheeraofcovid19abibliometricanalysis
AT vanderpuyevernadnk globalcancerresearchintheeraofcovid19abibliometricanalysis
AT murilloraul globalcancerresearchintheeraofcovid19abibliometricanalysis
AT boothchrism globalcancerresearchintheeraofcovid19abibliometricanalysis
AT canfellkaren globalcancerresearchintheeraofcovid19abibliometricanalysis
AT prameshcs globalcancerresearchintheeraofcovid19abibliometricanalysis
AT sullivanrichard globalcancerresearchintheeraofcovid19abibliometricanalysis
AT mukherijdeborah globalcancerresearchintheeraofcovid19abibliometricanalysis